June 6, 2010

Can Preemptive Cytomegalovirus Monitoring Be As Effective As Universal Prophylaxis When Implemented As the Standard of Care in Patients at Moderate Risk?


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

This retrospective study compares the strategy of universal prophylaxis to monitoring with serial PCR testing in patients at moderate risk for CMV disease post-transplant. All patients were CMV-positive pre-transplant and did not receive induction with a lymphocyte-depleting antibody. The incidence of CMV syndrome or infection was low in both groups, and costs were similar.

Renal Transplantation